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and cartilage explant models have demonstrated a clear stimu-
latory effect of Collagen Hydrolysate on chondrocyte metabolism
and cartilage growth. The objective of this study was to inves-
tigate the efﬁcacy of orally administered Collagen Hydrolysate
on the development and progression of osteoarthritis (OA) in an
appropriate animal model.
Methods: The inbred mouse strain STR/ort spontaneously de-
velops osteoarthritic lesions of the knee joint by 35 weeks of age
resembling human osteoarthritis. The efﬁcacy of Collagen Hy-
drolysate was tested in a randomly assigned placebo-controlled
animal study. In 6 month old male STR/ort mice 0.15 mg Colla-
gen Hydrolysate or BSA/g body weight was orally administered
once a day over a treatment period of 3 months. Thin sec-
tions of the knees were analyzed for osteoarthritic changes by
haematoxylin-eosin staining. OA joint damage was assessed by
a well-deﬁned semi-quantitative histopathological score. Addi-
tionally, the progression of osteoarthritis in male mice at different
ages was determined and the correlation between grade of OA
and body weight was investigated. A total number of 48 male
STR/ort mice were analyzed in this study.
Results: According to the literature the progression of the deter-
mined grade of OA in the non-treated STR/ort mice correlated
with the aging of the animals. While female mice developed
only mild forms of OA, 85% of the non-treated males showed
extensive OA-like lesions at the end of the study. The oral ad-
ministration of Collagen Collagen Hydrolysate over 3 months led
to a pronounced decrease in cartilage tissue degeneration in
the knee joints. The incidence of severe joint destruction was
clearly reduced after Collagen Hydrolysate treatment and the
determined grade of OA decreased statistically signiﬁcantly in
comparison to the untreated control animals.
Interestingly, a more detailed analysis of the data suggested a
correlation between the determined grade of OA and the body
weight of the STR/ort mice.
Conclusions: The results indicate that orally administered Col-
lagen Hydrolysate was able to slow or even halt cartilage de-
struction in STR/ort mice. The data suggest that Collagen Hy-
drolysate may prevent the progression of joint degeneration in
OA and could possibly be a potential disease-modifying agent
for the treatment of degenerative joint diseases.
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Purpose: This experimental study was undertaken to determine
whether viscosupplementation with intra-articular (i.a.) low- or
high-molecular-weight HA injections inﬂuences both chondral
and synovial lesions in rats with surgically-induced OA knee.
Methods: Male Wistar rats underwent anterior cruciate ligament
transection (ACLT). Rats were divided into 5 groups: naive group
(n=10), sham group (n=10), ACLT and saline i.a. injection group
(n=10), ACLT + Synvisc® (high molecular weight, HMW) i.a.
injection group (n=10), ACLT + Hyalgan® (low molecular weight,
LMW) i.a. injection group (n=10). Intra-articular injections of
sterile saline or HAs were performed on D7, D14, and D21 after
ACLT. Animals were killed on D28 for histological assessment.
Grading of chondral lesions was performed according to Mankin’s
score. Rooney’s score was used to assess concomitant synovitis.
Concomitant immunostainings of activated Caspase 3 and Hsp70
was also performed.
Results: Articular damages (D28) were signiﬁcantly reduced in
HAs-treated knee joints vs control joints: 17.55 for HMW and 19.2
for LMW vs 31.3 for ACLT control rats (p<0.05). In the cartilage
of ACLT+HAs treated groups, articular surface presented minor
ﬁbrillations. A signiﬁcant increase of histological score of synovial
membrane was noted in both ACLT+HAs groups (HMW, p<0.05;
LMW, p<0.05) versus matched ACLT+saline group. Both HAs-
treated groups exerted an inﬂamed synovial membrane. A basal
expression of caspase 3 (6,7%) was observed in the sham
group whereas it was signiﬁcantly increased in ACLT control rats
(23.9%). In contrast, apoptotic events signiﬁcantly decreased
in both HAs groups. Additionally, basal expression of Hsp 70
was quite similar in sham and ACLT groups. In contrast, Hsp70
increased signiﬁcantly in both HA groups.
Conclusions: Although previous works showed that hylan could
be responsible for synovial granulomatous inﬂammation in the
clinics, our pilot preliminary study conducted in the ACLT-induced
rat OA knee suggests that HAs may exert ambivalent properties
on articular structures, simultaneously exerting chondroprotective
properties and promoting synovitis
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Purpose: The intra-articular content of hyaluronic acid (HA)
generally declines in inﬂammatory arthritis (Carro & Blaya, 2002;
Takahasi et al, 2004). Intra-articular administration of HA has
been used historically, but less information is available about
the effectiveness of the oral route. The objective of this study
was to determine the effect of the oral administration of an HA
concentrate (Hyal-Joint™) on synovial ﬂuid quality and on the
clinical condition of horses with osteochondrosis (OCD).
Methods: The horse was used as an animal model because
allows the obtaining of high amounts of synovial ﬂuid at different
time points. Twelve horses with a radiographic diagnose of OCD
were randomly divided in two groups and assigned to receive
orally 250mg of Hyal-Joint (HJ) or placebo during 60 days in a
blinded randomized controlled clinical pilot trial. At the end of
the treatment (d60) and 30 days after ﬁnalization (d90) a sample
of synovial ﬂuid was extracted from each animal to analyse
HA concentration. The degree of synovial effusion measured
with ultrasonographic evaluation and the degree of lameness
according to AAEP scale were also evaluated.
Results: On day 0 no differences on intra-articular HA concen-
tration were detected among groups (353±45 vs. 301±137 µg/L
for HJ and placebo groups respectively). However during the
experimental period intra-articular HA concentration increased
numerically in the HJ group but decreased in the placebo group,
resulting in differences among groups on day 60 (384±42 vs.
209±104 µg/L; P=0.07) and on day 90 (424±89 vs. 286±119
µg/L; P=0.05) which tended to reach statistical signiﬁcance. In-
creases of the intra-articular HA concentration in HJ treated
horses were associated on d90 with numerical improvements
on the synovial effusion scale (1.25 vs. 2.00 points for treated
and control groups respectively) and on the degree of lameness
(0 vs. 1.5 degrees for treated and control groups respectively),
although differences among groups failed to reach statistical
signiﬁcance due to the reduced number of animals.
